Truncation in the tcdC region of the Clostridium difficilePathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A
Open Access
- 28 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 9 (1), 103
- https://doi.org/10.1186/1471-2334-9-103
Abstract
The increased severity of disease associated with the NAP1 strain of Clostridium difficile has been attributed to mutations to the tcdC gene which codes for a negative regulator of toxin production. To assess the role of hyper-production of Toxins A and B in clinical isolates of Clostridium difficile, two NAP1-related and five NAP1 non-related strains were compared. Sequencing was performed on tcdC, tcdR, and tcdE to determine if there were differences that might account for hyper-production of Toxin A and Toxin B in NAP1-related strains. Biological activity of Toxin B was evaluated using the HFF cell CPE assay and Toxin A biological activity was assessed using the Caco-2 Trans-membrane resistance assay. Our results confirm that Toxin A and Toxin B production in NAP1-related strains and ATCC 43255 occurs earlier in the exponential growth phase compared to most NAP1-nonrelated clinical isolates. Despite the hyper-production observed in ATCC 43255 it had no mutations in tcdC, tcdR or tcdE. Analysis of the other clinical isolates indicated that the kinetics and ultimate final concentration of Toxin A and B did not correlate with the presence or lack of alterations in tcdC, tcdR or tcdE. Our data do not support a direct role for alterations in the tcdC gene as a predictor of hyperproduction of Toxin A and B in NAP1-related strains.Keywords
This publication has 39 references indexed in Scilit:
- Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strainsJournal of Medical Microbiology, 2007
- tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficileJournal of Clinical Microbiology, 2007
- Comparative Phylogenomics of Clostridium difficile Reveals Clade Specificity and Microevolution of Hypervirulent StrainsJournal of Bacteriology, 2006
- Application of Mutated Clostridium difficile Toxin A for Determination of Glucosyltransferase-Dependent EffectsInfection and Immunity, 2006
- Construction and analysis of chromosomal Clostridium difficile mutantsMolecular Microbiology, 2006
- Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western CanadaJournal of Clinical Microbiology, 2006
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periodsJournal of Medical Microbiology, 2004
- Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical IsolatesJournal of Clinical Microbiology, 2002
- The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage® C. difficile panel, EIA for Tox A/B and cytotoxin assaysDiagnostic Microbiology and Infectious Disease, 2002